VISBEYO Trademark

Trademark Overview

On Monday, March 9, 2015, a trademark application was filed for VISBEYO with the United States Patent and Trademark Office. The USPTO has given the VISBEYO trademark a serial number of 86558367. The federal status of this trademark filing is REGISTERED as of Tuesday, June 11, 2019. This trademark is owned by Gilead Sciences Ireland UC. The VISBEYO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of HIV infection and hepatitis; antivirals; anti-inflammatories; anti-fungal medicines; pharmaceutical preparations for use in the treatment of infectious diseases, liver diseases and disorders, respiratory diseases and disorders, oncological diseases and disorders, hematological diseases and disorders and cardiovascular diseases and disorders
visbeyo

General Information

Serial Number86558367
Word MarkVISBEYO
Filing DateMonday, March 9, 2015
Status700 - REGISTERED
Status DateTuesday, June 11, 2019
Registration Number5772362
Registration DateTuesday, June 11, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 16, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of HIV infection and hepatitis; antivirals; anti-inflammatories; anti-fungal medicines; pharmaceutical preparations for use in the treatment of infectious diseases, liver diseases and disorders, respiratory diseases and disorders, oncological diseases and disorders, hematological diseases and disorders and cardiovascular diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 20, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGilead Sciences Ireland UC
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCarrigtohill Co. Cork,
IE
Party NameGilead Sciences Ireland UC
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCarrigtohill, Co. Cork
IE
Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCarrigtohill, Co. Cork
IE

Trademark Events

Event DateEvent Description
Monday, April 6, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 12, 2015NEW APPLICATION ENTERED
Friday, March 20, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 1, 2015ASSIGNED TO EXAMINER
Monday, April 6, 2015EXAMINERS AMENDMENT -WRITTEN
Monday, April 6, 2015EXAMINERS AMENDMENT E-MAILED
Monday, April 6, 2015EXAMINER'S AMENDMENT ENTERED
Sunday, October 18, 2015NON-FINAL ACTION E-MAILED
Monday, April 6, 2015SUSPENSION LETTER WRITTEN
Monday, April 6, 2015LETTER OF SUSPENSION E-MAILED
Monday, April 6, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, September 17, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, October 5, 2015ASSIGNED TO LIE
Saturday, October 17, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, October 17, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, October 18, 2015NON-FINAL ACTION WRITTEN
Sunday, October 18, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 12, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 8, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 15, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 15, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 5, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 13, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 27, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 16, 2016PUBLISHED FOR OPPOSITION
Tuesday, February 16, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, August 14, 2017SOU EXTENSION 3 FILED
Wednesday, August 10, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, August 10, 2016SOU EXTENSION 1 FILED
Wednesday, August 10, 2016SOU EXTENSION 1 GRANTED
Friday, August 12, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 7, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, February 7, 2017SOU EXTENSION 2 FILED
Tuesday, February 7, 2017SOU EXTENSION 2 GRANTED
Thursday, February 9, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 14, 2017SOU TEAS EXTENSION RECEIVED
Monday, August 14, 2017SOU EXTENSION 3 GRANTED
Tuesday, August 14, 2018SOU EXTENSION 5 GRANTED
Wednesday, August 16, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 27, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, February 27, 2018SOU EXTENSION 4 FILED
Tuesday, February 27, 2018SOU EXTENSION 4 GRANTED
Thursday, March 1, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 3, 2018SOU TEAS EXTENSION RECEIVED
Friday, August 3, 2018SOU EXTENSION 5 FILED
Tuesday, August 14, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 25, 2019NOTICE OF ALLOWANCE CANCELLED
Tuesday, June 11, 2019REGISTERED-PRINCIPAL REGISTER
Monday, October 11, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 25, 2019TEAS DELETE 1(B) BASIS RECEIVED
Monday, May 6, 20191(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, October 11, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 11, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 11, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 11, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 11, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

visbeyo diseases disorders pharmaceutical treatment anti preparations liver oncological cardiovascular hematological